Citigroup »

Adma Biologics shares owned by Citigroup

Quarter-by-quarter ownership of Adma Biologics (ADMA) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Adma Biologics

Tip: Access up to 7 years of quarterly data

All positions including Adma Biologics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adma Biologics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.7M 387k 19.99
2024-06-30 $1.2M 110k 11.33
2024-03-31 $4.2M 633k 6.67
2023-12-31 $1.2M 264k 4.67
2023-09-30 $1.0M 277k 3.67
2023-03-31 $2.6M 800k 3.31
2022-12-31 $1.4M 351k 3.88
2022-09-30 $1.3M 528k 2.43
2021-12-31 $8.0k 6.0k 1.33
2021-03-31 $8.0k 4.5k 1.77
2020-12-31 $24k 13k 1.92
2020-09-30 $19k 8.0k 2.38
2020-06-30 $41k 14k 2.95
2020-03-31 $70k 24k 2.87
2019-12-31 $97k 15k 6.54
2019-09-30 $24k 3.7k 6.54
2019-06-30 $29k 7.6k 3.87
2019-03-31 $21k 5.3k 3.93
2018-12-31 $12k 5.1k 2.42
2018-09-30 $33k 5.3k 6.23
2018-06-30 $12k 2.7k 4.42
2015-12-31 $0 5 0.00
2015-09-30 $17k 2.0k 8.48
2015-06-30 $0 5 0.00